Welcome to our dedicated page for L3Harris Technologies SEC filings (Ticker: LHX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The L3Harris Technologies, Inc. (NYSE: LHX) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on material events, such as the Form 8-K in which L3Harris reported its reorganization from four to three business segments and changes in senior leadership roles.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) give detailed information on L3Harris’ operations in areas such as Space & Mission Systems, Communications & Spectrum Dominance and Missile Solutions. Investors can review discussions of segment performance, risk factors related to defense and national security work, and descriptions of contracts and programs in space systems, missile propulsion, solid rocket motors, communications and electronic warfare.
Current reports on Form 8-K capture significant corporate events, including business segment reorganizations, portfolio transactions involving space propulsion and power assets, and announcements tied to major contracts or strategic partnerships. For those interested in governance and pay practices, proxy statements on Schedule 14A (when filed) outline board structures and executive compensation policies.
Stock Titan enhances these filings with AI-powered summaries that explain key points in clear language, helping readers interpret lengthy documents such as 10-K and 10-Q reports. Real-time updates from the SEC’s EDGAR system ensure that new L3Harris filings appear promptly, while access to Form 4 insider transaction reports allows users to monitor reported purchases and sales of LHX securities by directors and officers.
By combining original filings with AI-generated insights, this page helps investors, analysts and researchers understand how L3Harris communicates its strategy, risks and operational focus across its defense technology businesses.
David S. Regnery, a director of L3Harris Technologies, Inc. (LHX), received a credit of 124.8 phantom stock units under the companys 2019 Non-Employee Director Compensation Plan as reported for a 10/01/2025 transaction. The phantom units reflect a prior election to defer part of his non-employee director cash retainer and are payable in shares of the issuers common stock upon his separation from service. Following the credited units (including 6.82 phantom units added via dividend credits since last reported), the reporting persons beneficial holdings total 1,768.36 shares on a direct basis. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Christopher E. Kubasik, Chair and CEO of L3Harris Technologies (LHX), reported option exercise and a contemporaneous sale on 09/12/2025 under a Rule 10b5-1 plan. He exercised 83,000 non-qualified stock options with an exercise price of $162.30 per share that were originally granted 06/29/2019 and expire 02/20/2028, resulting in acquisition of 83,000 shares. The reporting person then sold 83,000 shares at a weighted-average price in the reported range of $278.30 to $281.62 (disclosed average shown as $279.90). Following these transactions, beneficial ownership is reported as 145,577.82 shares directly and indirectly, which includes 30,000 shares held indirectly through a grantor retained annuity trust.
L3Harris Technologies, Inc. (LHX) Rule 144 notice shows a proposed sale of 83,000 common shares through Fidelity Brokerage Services with an aggregate market value of $23,231,539.66, scheduled approximately for 09/12/2025 on the NYSE. The filing states these shares were acquired as an option granted on 02/20/2018 and the intended payment method is cash. The filer also disclosed three prior sales by Christopher E. Kubasik within the past three months: 33,061 shares on 06/12/2025 for $8,214,825.36, 72,000 shares on 07/29/2025 for $19,521,698.40, and 40,138 shares on 08/11/2025 for $10,818,005.80. The notice includes the standard insider representation that no undisclosed material adverse information is known.
Christopher E. Kubasik, Chair and CEO and a director of L3Harris Technologies (LHX), reported transactions dated 08/11/2025 involving company common stock. The filing shows a sale of 40,138 shares with weighted average sale prices reported in a range of $267.99 to $270.63. The report also discloses a non-qualified stock option position with an exercise price of $149.31 covering 40,138 shares (exercisable 06/29/2019, expiring 12/20/2027). The filing notes 30,000 shares held indirectly by a grantor retained annuity trust. All transactions were reported on a Form 4 signed by an attorney-in-fact.
Form 144 filed for L3Harris Technologies (LHX) shows an insider notice to sell 40,138 shares on 08/11/2025 on the NYSE, with an aggregate market value of $10,818,005.61. The filing identifies the seller in recent sale history as Christopher E. Kubasik and reports that the securities to be sold were acquired under an option granted on 12/20/2017 from the issuer, with payment in cash on 08/11/2025.
The filing also discloses three sales by Christopher E. Kubasik in the prior three months totaling 107,273 shares for $28,282,910.76 (sales on 06/11/2025, 06/12/2025 and 07/29/2025). The 40,138-share notice represents approximately 0.0215% of the 187,094,798 shares outstanding reported in the form; the prior three months' sales represent approximately 0.0573% of outstanding shares. The signer certifies no undisclosed material adverse information is known.
Form 4 highlights: On 07/29/2025 L3Harris Technologies (LHX) Chair & CEO Christopher E. Kubasik exercised 72,000 non-qualified stock options at an exercise price of $149.31 and simultaneously sold 72,000 common shares in the open market at a weighted-average price of $271.14 (range $269.92-$272.31). Following the transactions he now owns 145,577.82 shares directly and 30,000 shares indirectly through a grantor retained annuity trust.
The option, originally exercisable since 06/29/2019 and expiring 12/20/2027, was converted under code “M” (option exercise) and immediately disposed under code “S” (sale). The filing indicates routine reporting under Section 16 with no other derivative activity disclosed. Kubasik remains both a Director and the company’s Chair & CEO.
Key take-away: While the same-day sale represents sizeable insider monetization, the executive retains a meaningful equity stake that may continue to align his interests with shareholders.
FAQ
What is the current stock price of L3Harris Technologies (LHX)?
What is the market cap of L3Harris Technologies (LHX)?
